首页> 外国专利> Bifunctional molecules with antibody mobilization and entry inhibition activity against human immunodeficiency virus

Bifunctional molecules with antibody mobilization and entry inhibition activity against human immunodeficiency virus

机译:具有对抗人免疫缺陷病毒的抗体动员和进入抑制活性的双功能分子

摘要

The present invention is directed to new bifunctional compounds and methods for treating HIV infections. The bifunctional small molecules, generally referred to as ARM-HI's, function through orthogonal pathways, by inhibiting the gp120-CD4 interaction, and by recruiting anti-DNP antibodies to gp120-expressing cells, thereby preventing cell infection and spread of HIV. It has been shown that ARM-HI's bind to gp120 and gp-120 expressing cells competitively with CD4, thereby decreasing viral infectivity as shown by an MT-2 cell assay, the binding leading to formation of a ternary complex by recruiting anti-DNP antibodies to bind thereto, the antibodies present in the ternary complex promoting the complement-dependent destruction of the gp120-expressing cells. Compounds and methods are described herein.
机译:本发明涉及用于治疗HIV感染的新的双功能化合物和方法。双功能小分子(通常称为ARM-HI)通过抑制gp120-CD4相互作用,并通过向表达gp120的细胞募集抗DNP抗体,通过正交途径起作用,从而防止细胞感染和HIV传播。已经显示,ARM-HI与CD4竞争性结合至表达gp120和gp-120的细胞,从而降低了病毒的感染性,如MT-2细胞分析所示,该结合通过募集抗DNP抗体导致三元复合物的形成为了与之结合,存在于三元复合物中的抗体促进表达gp120的细胞的补体依赖性破坏。本文描述了化合物和方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号